-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
The use of calcium and vitamin D in the management of osteoporosis
Review
(2798) Views (1376) Full article downloads
Authors: John A Sunyecz
Published Date September 2008
Volume 2008:4(4) Pages 827 - 836
DOI: http://dx.doi.org/10.2147/TCRM.S3552
John A Sunyecz
MenopauseRx, Inc., Uniontown, PA, USA
Abstract: Osteoporosis poses a significant public health issue, causing significant morbidity and mortality. Calcium and vitamin D utilization in the optimization of bone health is often overlooked by patients and health care providers. In addition, the optimal standard of care for osteoporosis should encompass adequate calcium and vitamin D intake. Dietary intake or supplementation with calcium and vitamin D will be reviewed, including recent recommendations for increased vitamin D intake. Compliance to calcium and vitamin D therapy is paramount for effective prevention of osteoporotic fractures. A recently released algorithm (FRAX) estimating absolute fracture risk allows the health care provider to decide when pharmacologic therapy is warranted in addition to calcium and vitamin D. When pharmacologic therapy is advised, continued use of calcium and vitamin D is recommended for optimal fracture risk reduction. A ‘bricks and mortar’ analogy is often helpful when counseling patients and this analogy will be explained. This manuscript reviews relevant data related to calcium and vitamin D use for patients at risk for fracture due to bone loss.
Keywords: osteoporosis, calcium, vitamin D, osteopenia, hip fracture, bone
Other articles by Dr John Sunyecz
Zoledronic acid infusion for prevention and treatment of osteoporosis
Readers of this article also read:
Differences between the bisphosphonates for the prevention and treatment of osteoporosis
AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects
Fospropofol disodium injection for the sedation of patients undergoing colonoscopy
Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki
Bazedoxifene for the prevention of postmenopausal osteoporosis
Management of glucocorticoids-induced osteoporosis: role of teriparatide
Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
Zoledronic acid infusion for prevention and treatment of osteoporosis
Experience with alendronate treatment for four years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




